AP NEWS

Recent Advances in Targeted Therapies & Clinical Trial Analysis, 2018 Study - ResearchAndMarkets.com

December 17, 2018

DUBLIN--(BUSINESS WIRE)--Dec 17, 2018--The “Recent Advances in Targeted Therapies” report has been added to ResearchAndMarkets.com’s offering.

The Genetic Technology TechVision Opportunity Engine (TOE) presents trends across targeted treatment strategies. High impact diseases such as hemophilia B, autism spectrum disorder, Alzheimer’s disease, and cancer are highlighted. The corresponding clinical trials scenario is also depicted.

Key Topics Covered:

Innovations in Targeted Treatment Strategies

Adeno-associated Virus Therapy Shows Promising Results in Hemophilia B Patients Uncovering the Role of Gut Microbiome in Autism Spectrum Disorder Novel Antibody Treatment for Alzheimer’s Disease Selectively Targeting Cancer Genes

Clinical Trial Analysis and Key Contacts

Clinical Trial Analysis for Loxo Oncology Inc.’s Candidates Key Contacts

For more information about this report visit https://www.researchandmarkets.com/research/bmmnsj/recent_advances?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181217005263/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Genomics

KEYWORD:

INDUSTRY KEYWORD: HEALTH OTHER HEALTH

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/17/2018 04:25 AM/DISC: 12/17/2018 04:26 AM

http://www.businesswire.com/news/home/20181217005263/en

AP RADIO
Update hourly